Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1992 May 23;304(6838):1343–1346. doi: 10.1136/bmj.304.6838.1343

Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

M Brada 1, D Ford 1, S Ashley 1, J M Bliss 1, S Crowley 1, M Mason 1, B Rajan 1, D Traish 1
PMCID: PMC1882057  PMID: 1611331

Abstract

OBJECTIVE--To assess the risk of second brain tumour in patients with pituitary adenoma treated with conservative surgery and external beam radiotherapy. DESIGN--Long term follow up of a cohort of patients with pituitary adenoma and comparison of tumour occurrence with population incidence rates. SETTING--The Royal Marsden Hospital. SUBJECTS--334 patients with pituitary adenoma treated with conservative surgery and radiotherapy (median dose 45 Gy) and followed up for 3760 person years. MAIN OUTCOME MEASURES--Second intracranial tumour and systemic malignancy. RESULTS--Five patients developed a second brain tumour: two had astrocytoma, two meningioma, and one meningeal sarcoma. The cumulative risk of developing a second brain tumour over the first 10 years after treatment was 1.3% (95% confidence interval 0.4% to 3.9%) and over 20 years 1.9% (0.7% to 5.0%). The relative risk of a second brain tumour compared with the incidence in the normal population was 9.38 (3.05 to 21.89). There was no excess risk of any other type of second primary malignancy. CONCLUSIONS--There is an increased risk of second intracranial tumour in patients with pituitary adenoma treated with surgery and radiotherapy. Although radiation is likely to be the most important factor contributing to the excess risk, further study is required in a cohort of similar patients not receiving radiation.

Full text

PDF
1343

Images in this article

1345FIG 1
on p.1345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amendola B. E., Amendola M. A., McClatchey K. D. Radiation-induced malignant fibrous histiocytoma: a report of five cases including two occurring post whole brain irradiation. Cancer Invest. 1985;3(6):507–513. doi: 10.3109/07357908509039812. [DOI] [PubMed] [Google Scholar]
  2. Aristizabal S., Caldwell W. L., Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys. 1977 Jul-Aug;2(7-8):667–673. doi: 10.1016/0360-3016(77)90046-3. [DOI] [PubMed] [Google Scholar]
  3. Dowsett R. J., Fowble B., Sergott R. C., Savino P. J., Bosley T. M., Snyder P. J., Gennarelli T. A. Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):453–459. doi: 10.1016/0360-3016(90)90557-z. [DOI] [PubMed] [Google Scholar]
  4. Ebersold M. J., Quast L. M., Laws E. R., Jr, Scheithauer B., Randall R. V. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 1986 May;64(5):713–719. doi: 10.3171/jns.1986.64.5.0713. [DOI] [PubMed] [Google Scholar]
  5. Farwell J., Flannery J. T. Cancer in relatives of children with central-nervous-system neoplasms. N Engl J Med. 1984 Sep 20;311(12):749–753. doi: 10.1056/NEJM198409203111201. [DOI] [PubMed] [Google Scholar]
  6. Feek C. M., McLelland J., Seth J., Toft A. D., Irvine W. J., Padfield P. L., Edwards C. R. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors? Clin Endocrinol (Oxf) 1984 Apr;20(4):401–408. doi: 10.1111/j.1365-2265.1984.tb03435.x. [DOI] [PubMed] [Google Scholar]
  7. Flickinger J. C., Nelson P. B., Martinez A. J., Deutsch M., Taylor F. Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer. 1989 Jun 15;63(12):2409–2414. doi: 10.1002/1097-0142(19890615)63:12<2409::aid-cncr2820631206>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  8. Grigsby P. W., Simpson J. R., Emami B. N., Fineberg B. B., Schwartz H. G. Prognostic factors and results of surgery and postoperative irradiation in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1411–1417. doi: 10.1016/0360-3016(89)90942-5. [DOI] [PubMed] [Google Scholar]
  9. Halberg F. E., Sheline G. E. Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am. 1987 Sep;16(3):667–684. [PubMed] [Google Scholar]
  10. Harris J. R., Levene M. B. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 1976 Jul;120(1):167–171. doi: 10.1148/120.1.167. [DOI] [PubMed] [Google Scholar]
  11. Hawkins M. M., Draper G. J., Kingston J. E. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer. 1987 Sep;56(3):339–347. doi: 10.1038/bjc.1987.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kingston J. E., Hawkins M. M., Draper G. J., Marsden H. B., Kinnier Wilson L. M. Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer. 1987 Sep;56(3):331–338. doi: 10.1038/bjc.1987.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klibanski A., Zervas N. T. Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med. 1991 Mar 21;324(12):822–831. doi: 10.1056/NEJM199103213241207. [DOI] [PubMed] [Google Scholar]
  14. Parker R. G. Radiation-induced cancer as a factor in clinical decision making (the 1989 ASTRO Gold Medal address). Int J Radiat Oncol Biol Phys. 1990 May;18(5):993–1000. doi: 10.1016/0360-3016(90)90432-j. [DOI] [PubMed] [Google Scholar]
  15. Rimm I. J., Li F. C., Tarbell N. J., Winston K. R., Sallan S. E. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13-year experience from the Dana-Farber Cancer Institute and the Children's Hospital. Cancer. 1987 Apr 15;59(8):1506–1508. doi: 10.1002/1097-0142(19870415)59:8<1506::aid-cncr2820590819>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  16. Ron E., Modan B., Boice J. D., Jr, Alfandary E., Stovall M., Chetrit A., Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988 Oct 20;319(16):1033–1039. doi: 10.1056/NEJM198810203191601. [DOI] [PubMed] [Google Scholar]
  17. Ross D. A., Wilson C. B. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg. 1988 Jun;68(6):854–867. doi: 10.3171/jns.1988.68.6.0854. [DOI] [PubMed] [Google Scholar]
  18. Soffer D., Pittaluga S., Feiner M., Beller A. J. Intracranial meningiomas following low-dose irradiation to the head. J Neurosurg. 1983 Dec;59(6):1048–1053. doi: 10.3171/jns.1983.59.6.1048. [DOI] [PubMed] [Google Scholar]
  19. Tucker M. A., Coleman C. N., Cox R. S., Varghese A., Rosenberg S. A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988 Jan 14;318(2):76–81. doi: 10.1056/NEJM198801143180203. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES